Nykode Therapeutics ASA — Director's Dealing 2023

Nov 24, 2023

1	Details of the person discharging managerial responsibilities
a)	Name	Michael Engsig
b)	Position	Chief Executive Officer
2	Reason for notification
a)	Initial notification/	Initial
	Amendment
3	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options with shares in Nykode Therapeutics ASA (ISIN: NO0010714785) as underlying
b)	Nature of the transaction	Grant of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	2,910,000
d)	Aggregated information	Price	NOK 0
	-Average price,	Volume	2,910,000
	aggregated volume and total amount	Total amount	NOK 0
e)	Date of the transaction	24.11.2023
f)	Place of the transaction	Outside of trading venue